Chemical company suppresses dioxin report
Hay, A.
Nature 284(5751): 2
1980
ISSN/ISBN: 0028-0836 PMID: 7354872 Document Number: 159025
Document emailed within 1 workday
Related Documents
Catalani, S. 2010: IARC revision on dioxin and some dioxin-like compounds Giornale Italiano di Medicina del Lavoro Ed Ergonomia 32(1): 79-811982: Comments from the industrial council of the National Corporation for the Hydrogenation of Fuels and the Dauna Chemical Company on the arsenic occurrence La Medicina del Lavoro 73 Suppl. 3: 268-269
Evans, A.E. 1976: Anaconda Company and Chile Copper Company v. Overseas Private Investment Corporation. Case No. 16 10 0071 72 American Journal of International Law 70(1): 135-138
1988: Leads from the MMWR. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in Air Force Health Study participants--preliminary report JAMA 259(24): 3533 3535
Burton, B. 2001: Tobacco company prepares its first social responsibility report Bmj 323(7321): 1089
Fadahunsi, O. 1990: The State holding corporation in Nigeria : the evolution of the new Nigeria development company Ltd and ODU'a investment company Ltd Public Enterprise 10(1): 131-138
Fadahunsi, O. 1990: The State holding corporation in Nigeria : the evolution of the new Nigeria development company Ltd and ODU'a investment company Ltd Public Enterprise 10(1): 131-138
Lee, T.H. 1999: My insurance company won't pay for my prescription for Viagra without a letter from my doctor saying that I have been evaluated. As far as I know, I am the only one who can tell whether I have impotence. What does the insurance company want? Harvard Heart Letter: from Harvard Medical School 9(7): 7
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Haas, L. 1989: Reviews : Managing Your Diabetes (1988). Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. Patient booklet, 91 pages; flip chart, 87 pages; videotape, 14 modules. Price: Free educational service available through Eli Lilly and Company sales representatives Diabetes Educator 15(1): 90-91
Büchi, J.; Koller, R.J.; Perlia, X. 1975: Relations between chemical structure, physico-chemical properties, chemical reactivity and effect of various positionally isomeric local anesthetics 31.2 Arzneimittel-Forschung 25(1): 14-24
De Wilde, K. 1991: How toxic is dioxin for humans? Nederlands Tijdschrift Voor Geneeskunde 135(48): 2300
Turci, R.; Minoia, C.; Leoni, E.; Sturchio, E.; Boccia, P.; Meconi, C.; Zanellato, M.; Signorini, S.; Mantovani, A.; La Rocca, C.; Bianchi, F.; Imbriani, M. 2009: PCDD: polychlorodibenzo-4-dioxin Giornale Italiano di Medicina del Lavoro Ed Ergonomia 31(4): 325-370
Portier, C.; Lucier, G.; Damstra, T. 1995: Dioxin research in Vietnam Science 270(5238): 901
Westberg, G. 1988: Is dioxin dangerous for human beings? Lakartidningen 85(42): 3456
Bravo Mata, M. 1999: Dioxin contamination risk for children Anales Espanoles de Pediatria 51(5): 573-574
Sterling, J.B.; Hanke, C.W. 2005: Dioxin toxicity and chloracne in the Ukraine Journal of Drugs in Dermatology: Jdd 4(2): 148-150
Dunagin, W.G. 1983: Dioxin effects on human health Missouri Medicine 80(3): 127-131
Dunagin, W.G. 1983: Dioxin effects on human health Journal of the Indiana State Medical Association 76(6): 382-386
Cohen, D.; Swift, G. 2013: Laboratories and regulator misled over antibiotic susceptibility test discs: patients may have received inappropriate antibiotic treatment as a result of quality problems withone company's test discs, Deborah Cohen and Glenn Swift report Bmj 346: F837